FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282830047> ?p ?o ?g. }

• W4282830047 endingPage "63" @default.
• W4282830047 startingPage "63" @default.
• W4282830047 abstract "Clinical pharmacist interventions have resulted in optimized diabetes control in complex patients; however, there are no studies examining the durability of achieved outcomes after patients discontinued being seen by the pharmacist. A pharmacist-led comprehensive medication management (CMM) Diabetes Intensive Medication Management (DIMM) “tune up” clinic provided the opportunity to evaluate long-term glycemic control outcomes following clinical discharge. This study used a retrospective cohort study design with a matched primary care provider (PCP) comparison group. Outcomes were compared between the groups at several post-discharge intervals (6, 9, and 12 months) using independent t tests and chi-square tests, where appropriate. DIMM-managed patients achieved an average HbA1c reduction of 3% upon discharge, and maintained an average HbA1c concentration that was significantly lower than PCP-managed patients at 6 months (p < 0.001) and 9 months (p = 0.009) post-discharge. Although DIMM-managed patients had lower HbA1c than PCP-managed patients at 12 months post-discharge, the difference was not significant (p = 0.105). Similar findings were noted for average FPG and LDL across the study time points. No differences in average HDL levels were reported across the time points. A significantly larger proportion of DIMM-managed patients maintained HbA1c < 8% compared to PCP-managed patients at 6 months (67.5% versus 47.2%, p = 0.001) and 9 months (62.6% versus 40.6%, p = 0.040) post-discharge; DIMM-managed patients had a larger, but non-significant, proportion of goal retention compared to PCP-managed patients at 12 months (56.9% versus 47.2%, p = 0.126) post-discharge. Similarly, a significantly larger proportion of DIMM-managed patients sustained HbA1c < 9% compared to PCP-managed patients at 6 months (87.8% versus 66.7%, p < 0.001) and 9 months (82.1% versus 68.3%, p = 0.012) post-discharge; however, there was no significant difference at 12 months. The attenuation of the DIMM-managed metabolic biomarkers suggests that an additional follow-up visit or touchpoint may be helpful. The personalized care of the DIMM “tune up” approach was successful in achieving sustained glycemic control for up to 9 months. Outcomes can help inform future long-term result durability evaluations." @default.
• W4282830047 created "2022-06-15" @default.
• W4282830047 creator A5022918604 @default.
• W4282830047 creator A5036688434 @default.
• W4282830047 creator A5041303014 @default.
• W4282830047 creator A5051986130 @default.
• W4282830047 creator A5084405955 @default.
• W4282830047 creator A5090871191 @default.
• W4282830047 date "2022-06-13" @default.
• W4282830047 modified "2023-10-14" @default.
• W4282830047 title "Longitudinal Effects on Metabolic Biomarkers in Veterans 12 Months Following Discharge from Pharmacist-Provided Diabetes Care: A Retrospective Cohort Study" @default.
• W4282830047 cites W1943897317 @default.
• W4282830047 cites W1959235893 @default.
• W4282830047 cites W1997430032 @default.
• W4282830047 cites W2005171586 @default.
• W4282830047 cites W2033886860 @default.
• W4282830047 cites W2036193982 @default.
• W4282830047 cites W2041615764 @default.
• W4282830047 cites W2068907080 @default.
• W4282830047 cites W2073572818 @default.
• W4282830047 cites W2091080546 @default.
• W4282830047 cites W2099280290 @default.
• W4282830047 cites W2120271909 @default.
• W4282830047 cites W2126946832 @default.
• W4282830047 cites W2141993821 @default.
• W4282830047 cites W2143721482 @default.
• W4282830047 cites W2152289419 @default.
• W4282830047 cites W2157413365 @default.
• W4282830047 cites W2493860075 @default.
• W4282830047 cites W2556720182 @default.
• W4282830047 cites W2566176027 @default.
• W4282830047 cites W2591315819 @default.
• W4282830047 cites W2772643536 @default.
• W4282830047 cites W2792757017 @default.
• W4282830047 cites W2804506840 @default.
• W4282830047 cites W2905342096 @default.
• W4282830047 cites W2911908129 @default.
• W4282830047 cites W2975182929 @default.
• W4282830047 cites W2979812259 @default.
• W4282830047 cites W3046280637 @default.
• W4282830047 cites W3128220857 @default.
• W4282830047 cites W3163454829 @default.
• W4282830047 cites W3198824358 @default.
• W4282830047 cites W3209757261 @default.
• W4282830047 cites W3216819804 @default.
• W4282830047 cites W4238714725 @default.
• W4282830047 doi "https://doi.org/10.3390/pharmacy10030063" @default.
• W4282830047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35736778" @default.
• W4282830047 hasPublicationYear "2022" @default.
• W4282830047 type Work @default.
• W4282830047 citedByCount "1" @default.
• W4282830047 countsByYear W42828300472023 @default.
• W4282830047 crossrefType "journal-article" @default.
• W4282830047 hasAuthorship W4282830047A5022918604 @default.
• W4282830047 hasAuthorship W4282830047A5036688434 @default.
• W4282830047 hasAuthorship W4282830047A5041303014 @default.
• W4282830047 hasAuthorship W4282830047A5051986130 @default.
• W4282830047 hasAuthorship W4282830047A5084405955 @default.
• W4282830047 hasAuthorship W4282830047A5090871191 @default.
• W4282830047 hasBestOaLocation W42828300471 @default.
• W4282830047 hasConcept C104863432 @default.
• W4282830047 hasConcept C118552586 @default.
• W4282830047 hasConcept C126322002 @default.
• W4282830047 hasConcept C134018914 @default.
• W4282830047 hasConcept C160735492 @default.
• W4282830047 hasConcept C162324750 @default.
• W4282830047 hasConcept C167135981 @default.
• W4282830047 hasConcept C1862650 @default.
• W4282830047 hasConcept C194828623 @default.
• W4282830047 hasConcept C201903717 @default.
• W4282830047 hasConcept C27415008 @default.
• W4282830047 hasConcept C2779306644 @default.
• W4282830047 hasConcept C2779457091 @default.
• W4282830047 hasConcept C2780265253 @default.
• W4282830047 hasConcept C2780473172 @default.
• W4282830047 hasConcept C50522688 @default.
• W4282830047 hasConcept C512399662 @default.
• W4282830047 hasConcept C555293320 @default.
• W4282830047 hasConcept C71924100 @default.
• W4282830047 hasConcept C72563966 @default.
• W4282830047 hasConceptScore W4282830047C104863432 @default.
• W4282830047 hasConceptScore W4282830047C118552586 @default.
• W4282830047 hasConceptScore W4282830047C126322002 @default.
• W4282830047 hasConceptScore W4282830047C134018914 @default.
• W4282830047 hasConceptScore W4282830047C160735492 @default.
• W4282830047 hasConceptScore W4282830047C162324750 @default.
• W4282830047 hasConceptScore W4282830047C167135981 @default.
• W4282830047 hasConceptScore W4282830047C1862650 @default.
• W4282830047 hasConceptScore W4282830047C194828623 @default.
• W4282830047 hasConceptScore W4282830047C201903717 @default.
• W4282830047 hasConceptScore W4282830047C27415008 @default.
• W4282830047 hasConceptScore W4282830047C2779306644 @default.
• W4282830047 hasConceptScore W4282830047C2779457091 @default.
• W4282830047 hasConceptScore W4282830047C2780265253 @default.
• W4282830047 hasConceptScore W4282830047C2780473172 @default.
• W4282830047 hasConceptScore W4282830047C50522688 @default.
• W4282830047 hasConceptScore W4282830047C512399662 @default.
• W4282830047 hasConceptScore W4282830047C555293320 @default.

• next